albumin binding raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2025-10-12 and is reviewed periodically as new material appears.
Two related peptides circulate under the CJC-1295 label, and they differ mainly in how long they persist in circulation. The version carrying a drug affinity complex includes a maleimidopropionic acid linker that forms a covalent bond with serum albumin. The other version, usually written as modified GRF(1-29) or tetrasubstituted GRF(1-29), lacks that linker and is cleared quickly. Mixing the two produces inconsistent readings of published half-life values, because the linker rather than the receptor-facing sequence drives most of the difference.
The core sequence keeps the receptor-binding region of GHRH while replacing four positions that are vulnerable to dipeptidyl peptidase-4 and other proteases. Substitutions at positions 2, 8, 15, and 27 raise metabolic stability relative to the natural hormone. The N-terminal residues remain essential for activity, so changes there generally lower potency. Molecular weight sits near 3368 daltons for the tetrasubstituted analog without the linker, while the albumin-binding form is heavier because of the added maleimide group.
CJC-1295 is a synthetic peptide built as a long-acting analogue of growth hormone-releasing hormone. Its backbone matches the first twenty-nine residues of the natural human hormone, with four amino acid substitutions added to slow enzymatic breakdown. A reactive maleimide group, commonly termed the drug affinity complex, allows the peptide to attach to circulating albumin after administration. That albumin attachment keeps the molecule in the bloodstream for an extended period instead of being cleared within minutes.
The compound emerged from work at a Canadian biotechnology firm in the early 2000s. Early human studies examined its effect on growth hormone and insulin-like growth factor 1 in healthy volunteers and in people with HIV-associated fat redistribution. Reports described sustained increases in both markers after a single injection. Development did not advance to regulatory approval, and the clinical programme was later discontinued. The molecule is now encountered mainly as a research chemical rather than a marketed medicine.
Two forms circulate in research settings and are frequently confused. One carries the drug affinity complex and is often written as CJC-1295 with DAC; the other lacks that group and is usually called modified GRF(1-29). The two share the same core sequence but differ sharply in how long they persist in blood. Products labelled only as CJC-1295 normally refer to the version carrying the complex. Documentation that omits the distinction leaves the intended molecule ambiguous.
| Property | Value | Notes |
|---|---|---|
| Class | Synthetic peptide | GHRH receptor agonist |
| Sequence length | 29 amino acids | Derived from human GHRH |
| Molecular weight | About 3368 Da without linker | Albumin-binding form is heavier |
| Appearance | White to off-white lyophilized powder | Common form for research reference material |
| Typical storage | -20 °C or below, desiccated | Protect powder from light and moisture |
Reverse-phase high-performance liquid chromatography is the standard tool for purity assessment. The technique separates the target peptide from truncated or modified byproducts. Mass spectrometry confirms molecular weight and supports sequence verification. Electrospray ionization and matrix-assisted laser desorption are both used. Amino acid analysis provides an independent check on composition. Purity values are commonly reported as area percentage from the chromatogram. Residual trifluoroacetate and water content are also measured in many quality programs.
Batch-to-batch consistency depends on solid-phase peptide synthesis and subsequent purification. Coupling efficiency, resin choice, and cleavage conditions all affect the final profile. Counter-ion content and moisture can shift the apparent mass of a batch. Documentation typically includes a certificate of analysis with chromatograms and spectra. Independent verification by a second laboratory is sometimes requested. Whether a given certificate reflects the actual vial contents depends on chain of custody. Analytical methods themselves carry uncertainty that should be stated alongside results.
Lyophilized material is typically stored at minus twenty degrees Celsius or lower. Keeping the vial dry and protected from light preserves peptide integrity. Repeated freeze-thaw cycles can cause aggregation or loss of activity. Once dissolved, solutions are generally kept at two to eight degrees Celsius. Stability data for reconstituted solutions vary, and long-term behavior is not fully established. Working aliquots reduce the number of times a stock container is opened.
The two variants differ dramatically in how long they persist in circulation. The form lacking the albumin-binding group has a plasma half-life measured in tens of minutes, comparable to the natural hormone fragment. The version carrying the drug affinity complex binds albumin and shows a half-life of roughly six to eight days in human studies. That figure comes from small trials that tracked hormone levels over extended periods. The physiological consequences of sustained versus pulsatile stimulation are still debated and the literature does not settle the point.
Lyophilized peptide powder is comparatively stable when kept dry, cold, and protected from light. Once dissolved, the molecule is vulnerable to deamidation, oxidation, and aggregation, with the rate depending on pH, buffer composition, and temperature. Alkaline conditions and repeated freeze-thaw cycles accelerate loss of the intact peptide. The methionine present in the native sequence is a known oxidation site, which is one reason it was replaced in the modified fragment. Suppliers typically recommend cold storage of solutions and use within a short window.
Analytical confirmation usually relies on reversed-phase high-performance liquid chromatography for purity and on liquid chromatography coupled to mass spectrometry for identity. Mass data reveal the expected molecular mass and can flag truncated or oxidized species. Amino acid analysis and peptide mapping provide sequence-level verification. Immunoassays are used in some biological matrices, but antibodies raised against one releasing-hormone analog may cross-react with another. Reported purity figures depend heavily on the method used, so comparisons between suppliers require matching the analytical approach.
=== Other hump types === A common misconception says that camels store water in their humps. This is not true, however; as stated above, the humps store fat. If a camel is under stress, it will extract water from its rumen. The fat reserves themselves keep the camel from becoming thirsty, allowing for greater conservation of water.
=== Overview === There are 236 cave temples in Kizil, carved into the cliff stretching from east to west for a length of 2 km (1¼ miles). Of these, 135 are still relatively intact. The earliest caves are dated, based in part on radioactive carbon dating, to around the year 300. Most researchers believe that the caves were probably abandoned sometime around the beginning of the 8th century, after Tang influence reached the area. Documents written in Tocharian languages were found in Kizil and a few of the caves contain Tocharian and Sanskrit inscriptions which give the names of a few rulers. Many of the caves have a central pillar design, whereby pilgrims may circumambulate around a central column incorporating a niche for a statue of the Buddha, which is a representation of the stupa. There are three other types of caves: square caves, caves "with a colossal image", and monastic cells (kuti). Around two-thirds of the caves are kutis which are monks' living quarters and store-houses and these caves do not contain mural paintings. Chronology remains the subject of debate.
== Development == Half-Life 2: Deathmatch was started as a test while Half-Life 2 was being developed. Designer Adrian Finol wanted to know what it was like to use the gravity gun in a multiplayer setting, creating a build that showcased Half-Life 2 multiplayer. Scott Dalton created a map and the two played in the office, and Gabe Newell asked to be shown the product. Finol pushed for multiplayer so mod makers could access the tools to create their own levels. Upon the release and subsequent critical reception of Half-Life 2, reviewers expressed disappointment with the game's lack of multiplayer. Two weeks after the initial release of Half-Life 2, Valve revealed and released Half-Life 2: Deathmatch on Steam. Deathmatch was released simultaneously with the Source SDK as a means of promoting game modifications built upon the platform. Post-release, the game was supported with new maps from Valve as well as updates to the game and its engine. Valve's The Orange Box originally did not include Half-Life 2: Deathmatch, however, the game was upgraded to use the Orange Box version of the Source engine in September 2010. Valve announced a free promotional offer on January 10, 2008, which allowed NVIDIA graphics card users to download and play Half-Life 2: Deathmatch along with Portal: First Slice, Half-Life 2: Lost Coast, and Peggle Extreme. In September 2010, the game was released via Steam for OS X. A Linux version came more than two years later, in March 2013.
Sources: en.wikipedia.org
=== Books === Decoding Darkness: The Search for the Genetic Causes of Alzheimer's Disease. with Ann B, Parson. New York: Perseus Publishing, 2000. Super Brain: Unleashing the Explosive Power of Your Mind to Maximize Health, Happiness, and Spiritual Well-Being. New York: Harmony Books, Random House, 2012. Super Genes: Unlock the Astonishing Power of Your DNA for Optimum Health and Well-Being. New York: Harmony Books, Random House, 2015. The Healing Self: A Revolutionary New Plan to Supercharge Your Immunity and Stay Well for Life. New York: Harmony, Random House, 2018.
=== Proteins forming amyloids in human diseases === To date, 37 human proteins have been found to form amyloid in pathology and be associated with well-defined diseases. The International Society of Amyloidosis classifies amyloid fibrils and their associated diseases based upon associated proteins (for example ATTR is the group of diseases and associated fibrils formed by TTR). A table is included below.
=== Immunology === Immunology is the branch of medicine that deals with the immune system, a network of biological systems that protects humans from diseases. The immune system detects and responds to pathogens, such as viruses, bacteria, and parasites, as well as cancer cells and foreign bodies. Humans have two major immune subsystems: The innate immune system, which provides a preconfigured response (e.g. defensins, complement system) to broad groups of situations and stimuli; and the adaptive immune system, which provides a tailored response to each stimulus by developing an immunological memory of molecules previously encountered. Mechanisms common to both subsystems, include phagocytosis, humoural immunity, cell-mediated immunity.
=== Organic carbon === The removal of organic carbon from water is one of the differentiators between deionized water and ultrapure water. Sources include bacteria, leaching from plastic piping, and dissolved atmospheric sources. Organic carbon can be removed using filtration by activated carbon and oxidation of organic carbon to carbon dioxide/bicarbonate.
Sources: en.wikipedia.org
== Specimen processing == For blood tests, clinical chemists must process the specimen to obtain plasma and serum before testing for targeted analytes. This is most easily done by centrifugation, which packs the denser blood cells and platelets to the bottom of the centrifuge tube, leaving the liquid serum fraction resting above the packed cells. This initial step before analysis has recently been included in instruments that operate on the "integrated system" principle. Plasma is obtained by centrifugation before clotting occurs.
== See also == Dipeptidyl peptidase-4 Gastric inhibitory polypeptide GLP-1 receptor agonists—albiglutide, dulaglutide, exenatide, liraglutide, lixisenatide, tirzepatide, and semaglutide, the last of which is marketed under the brands Ozempic, Rybelsus, and Wegovy. Glucagon Glucagon-like peptide-1 receptor Glucagon-like peptide-2 Type 2 diabetes
=== Parenting === While there is no direct evidence of Tyrannosaurus raising their young (given the rarity of juvenile and nest Tyrannosaur fossils), it has been suggested that like its closest living relatives, birds and crocodiles, Tyrannosaurus may have protected and fed its young. Crocodilians and birds are often suggested by some paleontologists to be modern analogues for dinosaur parenting. Direct evidence of parental behavior exists in other dinosaurs such as Maiasaura peeblesorum, the first dinosaur to have been discovered to raise its young, as well as more closely related Oviraptorids, the latter suggesting parental behavior in theropods. Some very young specimens assigned to Tyrannosaurus rex suggest that, although the species may have provided parental care, it was likely limited.
Sources: en.wikipedia.org
Natural GHRH is degraded quickly by dipeptidyl peptidase-4 and related enzymes, giving it a half-life measured in minutes. CJC-1295 carries substitutions that slow that breakdown, so it stays intact longer. Both act at the same pituitary receptor and produce the same class of signal.
The label was first attached to the albumin-binding form during early development work. A shorter analog without the linker later became known by the same name in informal use. Published papers normally state which version was studied, so the methods section resolves the ambiguity.
It is a synthetic peptide rather than a steroid, and it does not occur naturally in the body. Its sequence is derived from a hypothalamic hormone called growth hormone-releasing hormone. It works as a receptor agonist rather than as a replacement for that hormone.
It is a synthetic peptide analogue of growth hormone-releasing hormone. Four substitutions in its sequence make it more resistant to enzymatic degradation than the natural hormone. In the version carrying a drug affinity complex, the peptide binds albumin and remains in circulation for days.